SCHEMBL6018249

SCHEMBL6018249

NC(=O)c1nc(-c2ccccc2)c(-c2ccccc2)[nH]1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 8/20 0.51
HPGD P15428 5/20 0.51
SMN1; SMN2 Q16637 1/20 0.51
POLB P06746 1/20 0.51
ALDH1A1 P00352 4/20 0.49
KMT2A Q03164 4/20 0.49
GLA P06280 2/20 0.49
GAA P10253 2/20 0.49
PTGES O14684 1/20 0.48
MGAM O43451 1/20 0.47
LMNA P02545 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
MEN1 O00255 2/20 0.47
CNR1 P21554 1/20 0.47
MAPK14 Q16539 3/20 0.46
MAPK13 O15264 2/20 0.46
MAPK12 P53778 2/20 0.46
MAPK11 Q15759 2/20 0.46
RAF1 P04049 1/20 0.46
MAPK9 P45984 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5274289 0.86 KDM4E (0.58) KDM4EHPGDSMN1; SMN2POLBALDH1A1
SCHEMBL11227523 0.83 KDM4E (0.51) KDM4EHPGDSMN1; SMN2POLBALDH1A1
SCHEMBL9321639 0.81 CDC7 (0.46) KDM4EALDH1A1GSK3B
SCHEMBL2454547 0.80 PTGES (0.52) KDM4EHPGDSMN1; SMN2POLBALDH1A1
SCHEMBL7267270 0.79 KDM4E (0.59) KDM4EHPGDSMN1; SMN2ALDH1A1KMT2A
SCHEMBL28144523 0.78 SCN9A (0.51) KDM4EHPGDALDH1A1KMT2AGAA
SCHEMBL10561379 0.78 CNR1 (0.51) KDM4EHPGDSMN1; SMN2POLBALDH1A1
SCHEMBL6184613 0.76 KCNMA1 (0.43) KDM4ESMN1; SMN2ALDH1A1KMT2AL3MBTL1
SCHEMBL11848374 0.76 ALDH1A1 (0.52) KDM4EHPGDSMN1; SMN2POLBALDH1A1
SCHEMBL7047758 0.75 KDM4E (0.51) KDM4EHPGDSMN1; SMN2POLBALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1675578-A2 USE OF EFFECTORS OF GLUTAMINYL AND GLUTAMATE CYCLASES Probiodrug AG (DE) 2006-07-05 EP disclosed
WO-2005039548-A2 USE OF EFFECTORS OF GLUTAMINYL AND GLUTAMATE CYCLASES PROBIODRUG AG (DE) 2005-05-06 WO disclosed